Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma.
about
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare DatabaseCost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.
P2860
Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@en
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@nl
type
label
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@en
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@nl
prefLabel
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@en
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness analysis of ...... lantation in multiple myeloma.
@en
P2093
Chintan Pandya
Katia Noyes
Mustaqeem Siddiqui
Nandita Khera
Shahrukh Hashmi
Shaji K Kumar
William Hogan
P2860
P304
P356
10.1111/CTR.12421
P577
2014-08-18T00:00:00Z